Sort
326,823 grants matching “clinical trial”
Frontotemporal Dementia: Genes, Images, and Emotions (supplement)
$1,791,998Bruce L Miller · University Of California, San Francisco · P01 · FY2022 · AG
A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
$1,791,855Jill Marie Johnsen · University Of Washington · UG3 · FY2022 · HL
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$1,791,773Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Delaware/Christiana Care community Oncology Research Program
$1,791,750Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2014 · CA
NCI Community Oncology Research Program Minority Underserved Community Sites
$1,791,736Carolyn Y Muller · University Of New Mexico Health Scis Ctr · UG1 · FY2018 · CA
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,791,702Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Aurora NCORP Community Site
$1,791,676Thomas J Saphner · Aurora Health Care, Inc. · UG1 · FY2024 · CA
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,791,614Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2024 · AG
University of Kansas Alzheimer's Disease Core Centers
$1,791,559Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2019 · AG
The District of Columbia Clinical Trials Unit (DC CTU)
$1,791,527Manya Magnus · George Washington University · UM1 · FY2023 · AI
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
$1,791,523Josh Levitsky · Northwestern University At Chicago · U01 · FY2022 · AI
Comprhensive Sickle Cell Center Program Project
$1,791,249Thomas Jefferson University · U54 · FY2003 · HL
Recanalization Therapies and Markers of Stroke Outcome
$1,791,105Joseph Paul Broderick · University Of Cincinnati · P50 · FY2009 · NS
Elafin Therapy for Pulmonary Arterial Hypertension
$1,790,971Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)
$1,790,846Mitchell S Elkind · Columbia University Health Sciences · U01 · FY2021 · NS
ADULT AIDS CLINICAL TRIALS UNIT
$1,790,506Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2004 · AI
Improving Cancer Outcome--Adaptive Helical Tomotherapy
$1,790,419University Of Wisconsin Madison · P01 · FY2004 · CA
Targeting the PD - 1 pathway to eradicate SIV/HIV
$1,790,318Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2015 · AI
Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN)
$1,790,249Michele Staton · University Of Kentucky · UG1 · FY2021 · DA
Behavioral Genomics of Alcohol Neuroadaptation
$1,789,795John C. Crabbe · Oregon Health & Science University · P60 · FY2010 · AA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HIV/AIDS Vaccine and Antibody Development
$1,789,546John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,789,540E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Fragments of TrpRS to Treat Neovascular Eye Diseases
$1,789,537Scripps Research Institute · R24 · FY2002 · EY